Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, October 30th.

Cumberland Pharmaceuticals (NASDAQ:CPIX) last announced its quarterly earnings data on Tuesday, August 8th. The specialty pharmaceutical company reported ($0.07) EPS for the quarter. The business had revenue of $8.67 million during the quarter. Cumberland Pharmaceuticals had a negative net margin of 19.57% and a negative return on equity of 0.13%. On average, analysts expect Cumberland Pharmaceuticals to post $0.09 EPS for the current fiscal year and $0.09 EPS for the next fiscal year.

Shares of Cumberland Pharmaceuticals Inc. (CPIX) traded down 1.89% during midday trading on Monday, hitting $7.26. The stock had a trading volume of 1,707 shares. Cumberland Pharmaceuticals Inc. has a 12-month low of $4.60 and a 12-month high of $7.61. The company’s 50-day moving average price is $7.06 and its 200-day moving average price is $6.80. The firm’s market cap is $115.40 million.

ILLEGAL ACTIVITY NOTICE: This piece was originally published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/23/cumberland-pharmaceuticals-inc-cpix-set-to-announce-quarterly-earnings-on-monday.html.

Cumberland Pharmaceuticals Company Profile

Cumberland Pharmaceuticals Inc (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company’s product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H.

Earnings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Receive News & Ratings for Cumberland Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.